Modifying Pasireotide Analogues For Improved Oral Peptide Delivery

Enhancing the oral bioavailability of peptide drug candidates is a major challenge in drug design. This thesis develops novel synthesised pasireotide analogues using a preclinical drug development pipeline, beginning with in vitro studies and through to in vivo studies in rats towards improved oral absorption.